regional anesthesia for SARS-CoV-2
Showing 1 - 25 of >10,000
Hypotension in SARS-CoV-2 (COVID-19) Pregnant Patients
Completed
- Hypotension
- +2 more
- spinal anesthesia induced hypotension in SARS-CoV-2 patients.
-
Ankara, Type A Choice Below ..., TurkeyAygün Güler
Oct 18, 2021
SARS-CoV-2 PANDEMIC AND FAILED SPINAL ANESTHESIA
Completed
- Regional Anesthesia
- SARS-CoV2 Infection
- covid 19 spinal anesthesia
-
Ankara, Type A Choice Below ..., TurkeyAygun Guler
Oct 18, 2021
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,
Not yet recruiting
- SARS-CoV-2 Infection
- +4 more
- Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023
SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)
Completed
- SARS-CoV-2 Virus
- SARS-CoV-2 RNA detection
-
Bangkok, Thailand2 Division of Nephrology,Department of Medicine Pramongkutklao H
Aug 31, 2023
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- Saline
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)
Recruiting
- SARS-CoV2 Infection
- General SARS-CoV-2 Communication
- Rural-Targeted SARS-CoV-2 Communication
-
Flint, MichiganFlint Journal Building
Oct 10, 2023
SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)
Active, not recruiting
- SARS-CoV-2
- SARS-CoV-2 mRNA vaccine (RBMRNA)
- CoronaVac®
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023
LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B
Not yet recruiting
- SARS-CoV-2
- +4 more
- LumiraDx SARS-CoV-2 Ag Ultra
- LumiraDx SARS-CoV-2 & Flu A/B
-
DeLand, FloridaHillcrest Medical Research
Feb 6, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
Nosocomial COVID-19 Infections in Patients Hospitalized at
Completed
- SARS CoV 2 Infection
- Nosocomial SARS-COV 2 Infection proportion
-
Metz, FranceCHR Metz-Thionville/Hopital de Mercy
Oct 5, 2022
SARS-CoV-2 Vaccination on Cancer Patients Infected With
Recruiting
- COVID-19 Infection
- COVID-19 Vaccine
- no intervention
-
Beijing, Beijing, ChinaSanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023
SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
- 0.9% sodium chloride solution
-
Islamabad, PakistanSindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023
COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)
Recruiting
- COVID-19
- the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
-
Guangzhou, Guangzhou, ChinaThe Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in
Active, not recruiting
- SARS-CoV-2 RNA Vaccines
- HIV Infection
- SARS-CoV-2 Vaccine
-
Sevilla, SpainVirgen del Rocio University Hospital
Dec 1, 2022
COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)
Not yet recruiting
- COVID-19 Vaccine
- COVID-19
- 50 μg Baiya SARS-CoV-2 Vax 2
- Placebo
-
Bangkok, ThailandQueen Saovabha Memorial Institute
May 23, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
COVID-19: SARS-CoV-2-CZ-PREVAL-II Study
Completed
- COVID-19
- SARS-CoV-2 Infection
- Quantitative analysis of SARS-CoV-2 antibodies
- Cellular immunity
-
Prague, CzechiaInstitute of Health Information and Statistics of the Czech Repu
Nov 25, 2022
COVID-19 Transmission and Morbidity in Malawi
Recruiting
- SARS CoV 2 Infection
- SARS CoV 2 Vaccination
-
Boston, Massachusetts
- +1 more
Aug 6, 2023
Sars-Covid-19 Vaccines in Haematological Patients: Prospective
Completed
- Hematologic Diseases
- IgG antibodies to Sars-Cov-2
- QuantiFERON SARS-CoV-2 test
-
Monza, Lombardia, ItalySan Gerardo Hospital
Jan 23, 2023
SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)
Not yet recruiting
- SARS-CoV-2 Infection
- +2 more
- eBAM Cov Testing
-
Marseille, France
- +1 more
Oct 23, 2023
SARS-CoV-2 Infection in Hematologic Tumors
Active, not recruiting
- SARS-CoV-2 Infection
- Hematologic Malignancy
- None intervention
-
Beijing, Beijing, ChinaPeking University First Hospital
Jan 13, 2023
SARS-CoV-2 Trial in Chengdu (RBMRNA-176, Placebo)
Active, not recruiting
- SARS-CoV-2
- RBMRNA-176
- Placebo
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023
EuGeni Rapid Antigen Test for Qualitative Detection of Severe
Terminated
- SARS-CoV-2 Infection
- EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test
-
Split, Croatia
- +4 more
Jan 3, 2023
Coronavirus Trial in Oxford (SARS-CoV-2 virus)
Recruiting
- Coronavirus
- SARS-CoV-2 virus
-
Oxford, Oxon, United Kingdom
- +2 more
Jan 5, 2023